Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2013

Nov 14, 2013

30071_dirs_2013-11-14_79b434e2-2c6c-4d0a-b6fc-89c1ebc5433e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-11-11

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-11 ResMed Common Stock F 3758 $50.74 Disposed 121070.345 Direct
2013-11-11 ResMed Common Stock F 2017 $50.74 Disposed 119053.345 Direct
2013-11-11 ResMed Common Stock F 5964 $50.74 Disposed 113089.345 Direct
2013-11-11 ResMed Common Stock F 3005 $50.74 Disposed 110084.345 Direct
2013-11-11 ResMed Common Stock F 3524 $50.74 Disposed 106560.345 Direct

Footnotes

F1: Disposition to issuer for tax withholding upon vesting of Performance-based Restricted Stock Units granted on 12/17/2009 and vesting on 11/11/2013.

F2: Includes 217.782 shares purchased on October 31, 2013, through the company's Employee Stock Purchase Plan.

F3: Disposition to issuer for tax withholding upon vesting of Performance-based Restricted Stock Units granted on 11/11/2010 and vesting on 11/11/2013.

F4: Disposition to issuer for tax withholding upon vesting of Performance-based Restricted Stock Units granted on 11/16/2011 and vesting on 11/11/2013.

F5: Disposition to issuer for tax withholding upon vesting of Performance-based Restricted Stock Units granted on 11/15/2012 and vesting on 11/11/2013.

F6: Disposition to issuer for tax withholding upon vesting of Performance-based Restricted Stock Units granted on 3/1/2013 and vesting on 11/11/2013.